PXS ASX Chart
Snapshot
Pharmaxis Limited (PXS) is involved in the research, development and commercialization of healthcare products for fibrotic (including some cancers) and inflammatory diseases. The company has a highly productive drug discovery engine, drug candidates in clinical trials and two respiratory products approved in global markets generating ongoing revenue.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -58.70% |
vs ASX 200 (1yr) | -69.77% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | - |
EPS | $0.00 |
DPS | $0.00 |
Book Value Per Share | $0.00 |
Broker Consensus
PXS is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.
Announcements
Corporate Overview
Corporate Details
Head Office | Frenchs Forest NSW 2086 |
Website | www.pharmaxis.com.au |
Registry | Computershare |
Auditor | PricewaterhouseCoopers |
Date Listed | 10 Nov 2003 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
09/02/2024 | Report (Interim) |
26/08/2024 | Report (Prelim) |
24/10/2024 | Report (Annual) |
Former Company Names
- Pharmaxis Limited PXS (11/11/2003)
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
PXS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of PXS directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Biotechnology Value Fund, Inc | 14/09/2023 | 102,778,714 | 14.00 |
Karst Peak Capital Limited | 14/09/2023 | 87,940,615 | 12.00 |
Platinum Investment Management Limited | 14/09/2023 | 56,488,849 | 8.00 |
D and A Income Limited | 14/09/2023 | 84,453,719 | 12.00 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
09-08-23 | D and A Income Limited | 7,542,878 | 10.68 | 11.72 |
30-06-23 | D and A Income Limited | 7,309,534 | 9.68 | 10.68 |
20-03-23 | Bank of America Corporation and its related bodies corporate | 36,651,226 | -- | 5.09 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
24-07-23 | Regal Funds Management Pty Ltd | 38,159,163 | 5.30 | -- |
29-03-23 | Bank of America Corporation and its related bodies corporate | 36,651,226 | 5.09 | -- |
17-03-23 | Regal Funds Management Pty Ltd | 9,177,685 | 6.58 | 5.30 |
09-02-23 | Regal Funds Management Pty Ltd | 9,412,792 | 7.89 | 6.58 |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.03 | 30 November |
2023 | $0.049 | 30 June |
2022 | $0.065 | 30 June |
2021 | $0.089 | 30 June |
2020 | $0.066 | 30 June |
2019 | $0.255 | 28 June |
2018 | $0.31 | 29 June |
2017 | $0.25 | 30 June |
2016 | $0.255 | 30 June |
2015 | $0.22 | 30 June |
2014 | $0.066 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.